FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
NCT01703234
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Proteinuria
Diabetic Nephropathy
Chronic Kidney Disease
Interventions
DRUG:
Ramipril
Sponsor
Gulhane School of Medicine